Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Susan G, Groshen"'
Autor:
Jocelyn Garcia-Sayre, Yvonne G. Lin, Koji Matsuo, Denice D. Tsao-Wei, Paulette Mhawech-Fauceglia, Stan Louie, Tiange Dong, Marcia A. Ciccone, Laurie L. Brunette-Masi, Huyen Q. Pham, Annie A. Yessaian, Susan G. Groshen, Grace Facio, Marissa Aldana, Laila I. Muderspach, Agustin A. Garcia, Lynda D. Roman
Publikováno v:
Gynecologic Oncology. 173:49-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46b1835eca85f53e696326c4f5b1fb9e
https://doi.org/10.1016/j.ygyno.2023.02.016
https://doi.org/10.1016/j.ygyno.2023.02.016
Autor:
Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser, Jemily Malvar, Yueh-Yun Chi, Susan G. Groshen, Judith G. Villablanca, Kateryna Krytska, Lillian M. Lai, Patricia T. Acharya, Fariba Goodarzian, Bruce Pawel, Hiroyuki Shimada, Susan Ghazarian, Lisa States, Lynley Marshall, Louis Chesler, Meaghan Granger, Ami V. Desai, Rajen Mody, Daniel A. Morgenstern, Suzanne Shusterman, Margaret E. Macy, Navin Pinto, Gudrun Schleiermacher, Kieuhoa Vo, Holger C. Thurm, Joseph Chen, Marlon Liyanage, Gerson Peltz, Katherine K. Matthay, Esther R. Berko, John M. Maris, Araz Marachelian, Yael P. Mossé
Publikováno v:
Nature Medicine. 29:1092-1102
Neuroblastomas harbor ALK aberrations clinically resistant to crizotinib yet sensitive pre-clinically to the third-generation ALK inhibitor lorlatinib. We conducted a first-in-child study evaluating lorlatinib with and without chemotherapy in childre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05cb1069b5caae85576f8251b56aaa50
https://doi.org/10.1038/s41591-023-02297-5
https://doi.org/10.1038/s41591-023-02297-5
Autor:
Yves A. DeClerck, C. Patrick Reynolds, Wei Ye, Susan G. Groshen, Marvin D. Nelson, Rex A. Moats, Yasuyoshi Sohara, Hongjun Peng
Metastasis to the bone is seen in 56% of patients with neuroblastoma and contributes to morbidity and mortality. Using a murine model of bone invasion, we have reported previously that neuroblastoma cells invade the bone by activating osteoclasts. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94fb76e06e189d4f9ef32a11c57953e4
https://doi.org/10.1158/0008-5472.c.6496725
https://doi.org/10.1158/0008-5472.c.6496725
Autor:
Yves A. DeClerck, Robert C. Seeger, Susan G. Groshen, Leonid S. Metelitsa, Heidi V. Russell, Nino Keshelava, Hiroyuki Shimada, Liping Song, Tasnim Ara
Neuroblastoma, the second most common solid tumor in children, frequently metastasizes to the bone marrow and the bone. Neuroblastoma cells present in the bone marrow stimulate the expression of interleukin-6 (IL-6) by bone marrow stromal cells (BMSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f6aa38e7f5567eb36673e7c4302272
https://doi.org/10.1158/0008-5472.c.6498369
https://doi.org/10.1158/0008-5472.c.6498369
Autor:
Yves A. DeClerck, Robert C. Seeger, Susan G. Groshen, Leonid S. Metelitsa, Heidi V. Russell, Nino Keshelava, Hiroyuki Shimada, Liping Song, Tasnim Ara
Supplementary Figure 4 from Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f31f26336a54e021f427e728d53635c
https://doi.org/10.1158/0008-5472.22376913.v1
https://doi.org/10.1158/0008-5472.22376913.v1
Autor:
Yves A. DeClerck, C. Patrick Reynolds, Wei Ye, Susan G. Groshen, Marvin D. Nelson, Rex A. Moats, Yasuyoshi Sohara, Hongjun Peng
Supplementary Figure 6 from The Activity of Zoledronic Acid on Neuroblastoma Bone Metastasis Involves Inhibition of Osteoclasts and Tumor Cell Survival and Proliferation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d6525df00d94c3d300ef11124e7565
https://doi.org/10.1158/0008-5472.22371282.v1
https://doi.org/10.1158/0008-5472.22371282.v1
Autor:
Yves A. DeClerck, Robert C. Seeger, Richard Jove, Hua Yu, Lingyun Ji, Susan G. Groshen, Ralf Buettner, Hiroyuki Shimada, Michael A. Sheard, Rie Nakata, Tasnim Ara
Legends to supplementary figures - PDF file 87K, Legends to supplementary figures 1 to 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab038ccf8f82c8ee0d460acf7b83959b
https://doi.org/10.1158/0008-5472.22396724.v1
https://doi.org/10.1158/0008-5472.22396724.v1
Autor:
Yves A. DeClerck, Robert C. Seeger, Susan G. Groshen, Leonid S. Metelitsa, Heidi V. Russell, Nino Keshelava, Hiroyuki Shimada, Liping Song, Tasnim Ara
Supplementary Figure 2 from Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31da5ad9bd61e9f14bb759ec6d5f049a
https://doi.org/10.1158/0008-5472.22376919.v1
https://doi.org/10.1158/0008-5472.22376919.v1
Autor:
Yves A. DeClerck, Robert C. Seeger, Richard Jove, Hua Yu, Lingyun Ji, Susan G. Groshen, Ralf Buettner, Hiroyuki Shimada, Michael A. Sheard, Rie Nakata, Tasnim Ara
Supplementary Figure 3 - PDF file 455K, A. CHLA-255 cells were cultures alone or in the presence of sIL-6R (25ng/mL) or IL-6 (10 ng/mL) before being treated with etoposide as indicated in Figure 3. After 24 hours, cells were examined for Annexin V ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fbdde80659a505793ebcb23fc3240f1
https://doi.org/10.1158/0008-5472.22396715.v1
https://doi.org/10.1158/0008-5472.22396715.v1
Autor:
Yves A. DeClerck, Robert C. Seeger, Richard Jove, Hua Yu, Lingyun Ji, Susan G. Groshen, Ralf Buettner, Hiroyuki Shimada, Michael A. Sheard, Rie Nakata, Tasnim Ara
Supplementary Figure 1 - PDF file 231K, Inhibition of STAT3 activation in CHLA-255 cells by anti-IL-6R blocking antibody. A, Expression of pSTAT3 and STAT3 in CHLA-255 cells was examined by Western blot analysis as in Fig. 1A. When indicated, cells w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5e129fc80f1f8964dca59002bebd46
https://doi.org/10.1158/0008-5472.22396721
https://doi.org/10.1158/0008-5472.22396721